Ultragenyx Pharmaceutical
RARE
#4434
Rank
C$3.26 B
Marketcap
C$33.86
Share price
2.87%
Change (1 day)
-47.02%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: C$3.26 Billion

As of February 2026 Ultragenyx Pharmaceutical has a market cap of C$3.26 Billion. This makes Ultragenyx Pharmaceutical the world's 4434th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026C$3.26 B-27.69%
2025C$4.51 B-21.49%
2024C$5.75 B10.47%
2023C$5.20 B18.17%
2022C$4.40 B-39.66%
2021C$7.30 B-37.44%
2020C$11.67 B261.93%
2019C$3.22 B7.1%
2018C$3.01 B21.3%
2017C$2.48 B-35.67%
2016C$3.86 B-36.19%
2015C$6.05 B272.08%
2014C$1.62 B

End of Day market cap according to different sources

On Feb 2nd, 2026 the market cap of Ultragenyx Pharmaceutical was reported to be:

C$3.26 Billion
by Nasdaq info icon info icon
C$3.26 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Lexicon Pharmaceuticals
LXRX
C$0.62 B-80.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$1.14 B-64.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C$6.12 B 87.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$15.22 B 366.05%๐Ÿ‡บ๐Ÿ‡ธ USA